Dark Forest Capital Management LP Immunity Bio, Inc. Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.23 - $6.17 $146,748 - $280,321	45,433 New	45,433 $243,000
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $311,560 - $1.31 Million	203,634 Added 814536.0%	203,659 $566,000
Q1 2023 May 12, 2023	BUY	$1.35 - $4.78 $33 - $119	25 New	25 $0
Q1 2022 May 13, 2022	SELL	$5.05 - $7.53 $232 - $346	-46 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.67 - $10.18 $260 - $468	46 New	46 $0
Q3 2021 Nov 12, 2021	SELL	$9.17 - $14.24 $33,855 - $52,574	-3,692 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $49,509 - $82,700	3,692 New	3,692 $53,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.